We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$19.6B
AUM Growth
+$6.69B
Cap. Flow
+$6.14B
Cap. Flow %
31.32%
Top 10 Hldgs %
38.67%
Holding
659
New
42
Increased
95
Reduced
265
Closed
61

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$62M
2
WFC icon
Wells Fargo
WFC
+$37.5M
3
KMX icon
CarMax
KMX
+$33.1M
4
EMR icon
Emerson Electric
EMR
+$32.3M
5
EVR icon
Evercore
EVR
+$27.3M

Sector Composition

Rank Sector Weight
1 Financials 8.45%
2 Technology 7.68%
3 Healthcare 6.17%
4 Consumer Discretionary 5%
5 Communication Services 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBR icon
276
Petrobras
PBR
$121B
$4.65M 0.02%
451,575
+44,150
+11% +$451K
RF icon
277
Regions Financial
RF
$26.3B
$4.63M 0.02%
267,844
-5,388
-2% -$86.2K
TPR icon
278
Tapestry
TPR
$28.8B
$4.62M 0.02%
104,330
-2,212
-2% -$91.2K
STT icon
279
State Street
STT
$50.9B
$4.6M 0.02%
47,155
-1,064
-2% -$102K
EW icon
280
Edwards Lifesciences
EW
$47.6B
$4.49M 0.02%
119,616
-5,865
-5% -$215K
ATVI
281
DELISTED
Activision Blizzard
ATVI
$4.46M 0.02%
70,351
-1,632
-2% -$103K
NI icon
282
NiSource
NI
$22.4B
$4.45M 0.02%
173,414
-3,676
-2% -$97.6K
VALE icon
283
CALL
Vale
VALE
$62.9B
$4.32M 0.02%
+410,000
New +$4.35M
FCX icon
284
Freeport-McMoran
FCX
$90B
$4.3M 0.02%
226,669
+2,537
+1% +$38.3K
VRTX icon
285
Vertex Pharmaceuticals
VRTX
$121B
$4.3M 0.02%
28,682
-547
-2% -$81K
CMI icon
286
Cummins
CMI
$91.7B
$4.25M 0.02%
24,088
-963
-4% -$165K
STI
287
DELISTED
SunTrust Banks, Inc.
STI
$4.23M 0.02%
65,444
-1,461
-2% -$89.2K
VAR
288
DELISTED
Varian Medical Systems, Inc.
VAR
$4.21M 0.02%
37,912
-803
-2% -$86.3K
PPG icon
289
PPG Industries
PPG
$25.9B
$4.2M 0.02%
35,970
-763
-2% -$88K
FITB
290
Fifth Third Bancorp
FITB
$52B
$4.19M 0.02%
138,174
-2,654
-2% -$77.4K
MAC icon
291
Macerich
MAC
$7.32B
$4.19M 0.02%
63,781
-1,353
-2% -$82.8K
ADSK icon
292
Autodesk
ADSK
$44.3B
$4.17M 0.02%
39,743
-843
-2% -$98.3K
KMI icon
293
Kinder Morgan
KMI
$73.1B
$4.16M 0.02%
230,450
-4,872
-2% -$87.4K
KMB icon
294
Kimberly-Clark
KMB
$36.4B
$4.14M 0.02%
34,281
-2,086
-6% -$243K
FE icon
295
FirstEnergy
FE
$28.9B
$4.12M 0.02%
134,432
-2,752
-2% -$89.4K
CUK
296
CALL
DELISTED
Carnival PLC
CUK
$4.12M 0.02%
62,000
GLF
297
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$4.11M 0.02%
+144,113
New +$4.04M
DG icon
298
Dollar General
DG
$25.9B
$4.1M 0.02%
44,045
-934
-2% -$80.3K
LKQ icon
299
LKQ Corp
LKQ
$6.58B
$4.08M 0.02%
100,357
-1,984
-2% -$75.9K
BALL icon
300
Ball Corp
BALL
$17B
$4.06M 0.02%
107,184
-2,272
-2% -$92.2K

Similar funds

Calamos Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Calamos Advisors held 659 positions worth $19.6B, up 52% from $12.9B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Calamos Advisors deployed $6.14B of net new capital in Q4 2017, opening 42 new positions and adding to 95 existing holdings. Its largest new stake was Evercore: 327,688 shares worth $29.5M.

By sector, the portfolio is most concentrated in Financials at 8.5% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Citigroup, an estimated $92.2M trimmed.

  • Calamos Advisors's largest Q4 2017 buy was Evercore: 327,688 shares worth $29.5M.
  • Calamos Advisors added most to AbbVie in Q4 2017, an estimated $62M increase.
  • Calamos Advisors's biggest Q4 2017 reduction was Citigroup, cutting an estimated $92.2M.
  • Calamos Advisors fully exited T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2017, selling an estimated $51.1M.
  • Calamos Advisors's ten largest holdings make up 39% of its $19.6B portfolio in Q4 2017.
  • Calamos Advisors opened 42 new positions and closed 61 in Q4 2017.
  • Calamos Advisors's portfolio value rose 52% quarter-over-quarter to $19.6B.

Based on Calamos Advisors's 13F filing for Q4 2017, filed 13 Feb 2018.